Halozyme Therapeutics Inc. (Nasdaq: HALO) announced a public offering of $100 million worth of common stock. Shares of the biotechnology firm tumbled $1.25 to close at $12.91.
Halozyme Therapeutics announces public offering
May 19, 2017 at 19:26 PM EDT
